Cargando…

Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis

Liver cirrhosis leads to hepatic dysfunction and life-threatening conditions. Although the clinical efficacy of autologous bone marrow-derived mesenchymal stem cells (BM-MSC) transplantation in alcoholic cirrhosis (AC) was demonstrated, the relevant mechanism has not been elucidated. We aimed to ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Haripriya, Youn, Gi Soo, Han, Sang Hak, Shin, Min Jea, Yoon, Sang Jun, Han, Dae Hee, Lee, Na Young, Kim, Dong Joon, Baik, Soon Koo, Suk, Ki Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616969/ https://www.ncbi.nlm.nih.gov/pubmed/31212896 http://dx.doi.org/10.3390/jcm8060862

Ejemplares similares

Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
por: Kim, Ji Hyun, et al.
Publicado: (2020)

Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis
por: Gupta, Haripriya, et al.
Publicado: (2022)

Role of Gut Microbiota in Hepatocarcinogenesis
por: Gupta, Haripriya, et al.
Publicado: (2019)

Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Patients with Cirrhosis and Healthy Volunteers Show Comparable Characteristics
por: Lim, Yoo Li, et al.
Publicado: (2020)

Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
por: Jang, Yoon Ok, et al.
Publicado: (2014)

Nutritional Status and Diet Style Affect Cognitive Function in Alcoholic Liver Disease
por: Choi, Ye Rin, et al.
Publicado: (2021)

Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
por: Jang, Yoon Ok, et al.
Publicado: (2015)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Effect of Korean Red Ginseng on metabolic syndrome
por: Yoon, Sang Jun, et al.
Publicado: (2021)

The Accuracy of Ultrasonography for the Evaluation of Portal Hypertension in Patients with Cirrhosis: A Systematic Review
por: Kim, Gaeun, et al.
Publicado: (2015)

Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver
por: Gupta, Haripriya, et al.
Publicado: (2021)

Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) Reduce the Expression of Toll-Like Receptor 4 in Mice with Alcoholic Liver Disease
por: Hong, Meegun, et al.
Publicado: (2015)

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis
por: Cho, Eun Ju, et al.
Publicado: (2015)

The juxtaposition of Ilex cornuta fruit and gut microbiota against alcoholic liver disease based on the integrated pharmacology via metabolomics
por: Oh, Ki‐Kwang, et al.
Publicado: (2023)

Effects of Korean Red Ginseng (Panax ginseng), urushiol (Rhus vernicifera Stokes), and probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut–liver axis of alcoholic liver disease
por: Bang, Chang Seok, et al.
Publicado: (2014)

The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
por: Lim, Yoo Li, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease: Definition and subtypes
por: Han, Seul Ki, et al.
Publicado: (2023)

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Han, Seul Ki, et al.
Publicado: (2023)

Clinical Features and Treatment Outcomes of Upper Gastrointestinal Bleeding in Patients with Cirrhosis
por: Seo, Yeon Seok, et al.
Publicado: (2008)

Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
por: Shin, Sangdeok, et al.
Publicado: (2020)

Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease
por: Hyun, Ji Ye, et al.
Publicado: (2022)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol
por: Yoon, Jae Hyun, et al.
Publicado: (2021)

Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications
por: Raja, Ganesan, et al.
Publicado: (2021)

Lactobacillus lactis and Pediococcus pentosaceus‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver disease
por: Yu, Jeong Seok, et al.
Publicado: (2021)

Relationship of Hemodynamic Indices and Prognosis in Patients with Liver Cirrhosis
por: Baik, Soon Koo, et al.
Publicado: (2004)

Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study
por: Kim, Ji Hyun, et al.
Publicado: (2022)

The Role of the Gut Microbiome in Liver Cirrhosis Treatment
por: Lee, Na Young, et al.
Publicado: (2020)

The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis
por: Ryu, Se Ri, et al.
Publicado: (2021)

Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function
por: Hong, Ji Taek, et al.
Publicado: (2021)

Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis
por: Kim, Ji Hyun, et al.
Publicado: (2018)

Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis
por: Jang, Dong Kee, et al.
Publicado: (2021)

The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis
por: Kang, Seong Hee, et al.
Publicado: (2018)

Relationship between the hepatic venous pressure gradient and first variceal hemorrhage in patients with cirrhosis: a multicenter retrospective study in Korea
por: Kim, Jin Nyoung, et al.
Publicado: (2012)

Helicobacter pylori Infection and Peptic Ulcer Disease in Patients with Liver Cirrhosis
por: Kim, Dong Joon, et al.
Publicado: (2008)

Revision and update on clinical practice guideline for liver cirrhosis
por: Suk, Ki Tae, et al.
Publicado: (2012)

Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study
por: Park, Min Sun, et al.
Publicado: (2018)

Clinical Features and Prognosis of Spontaneous Bacterial Peritonitis in Korean Patients with Liver Cirrhosis: A Multicenter Retrospective Study
por: Heo, Jeong, et al.
Publicado: (2009)

Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis
por: Kim, Gaeun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u49bmh3dve5n3bnsihoouiqcoa